Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein

Virology

Volumn 352, Issue 2, 2006, Pages 357-367

  Troesch, Myriam ^a,b   Meunier, Isabelle ^a,b   Lapierre, Pascal ^a,b   Lapointe, Normand ^a,b   Alvarez, Fernando ^a,b   Boucher, Marc ^a,b   Soudeyns, Hugo ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Envelope; Hepatitis C virus; Molecular modeling; Positive selection; Quasispecies

Indexed keywords

AMINO ACID; CELL SURFACE RECEPTOR; GLYCOPROTEIN E2; NUCLEIC ACID; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ADULT; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIGENICITY; ARTICLE; ENTROPY; GENETIC ANALYSIS; GENETIC DISTANCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; VALIDATION PROCESS;

BASE SEQUENCE; CHEMISTRY, PHYSICAL; DNA, VIRAL; FEMALE; GENES, VIRAL; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; MODELS, MOLECULAR; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROTEIN CONFORMATION; SELECTION (GENETICS); VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS;

EID: 33747051965     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.05.015     Document Type: Article

References (65)

1. Abbate I., Lo Iacono O., Di Stefano R., Cappiello G., Girardi E., Longo R., Ferraro D., Antonucci G., Di Marco V., Solmone M., Craxi A., Ippolito G., and Capobianchi M.R. HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin. J. Hepatol. 40 (2004) 831-836
2. Alter M.J., Margolis H.S., Krawczynski K., Judson F.N., Mares A., Alexander W.J., Hu P.Y., Gerber M.A., Sampliner R.E., Meeks E.L., and Beach M.J. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N. Engl. J. Med. 327 (1992) 1899-1905
3. + T cell homeostasis and function in advanced HIV disease. Science 277 (1997) 112-116
4. Bach N., Thung S.N., and Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 15 (1992) 572-577
5. Barth H., Schafer C., Adah M.I., Zhang F., Linhardt R.J., Toyoda H., Kinoshita-Toyoda A., Toida T., Van Kuppevelt T.H., Depla E., Von Weizsacker F., Blum H.E., and Baumert T.F. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 278 (2003) 41003-41012
6. Benhamou Y., Di Martino V., Bochet M., Colombet G., Thibault V., Liou A., Katlama C., and Poynard T. Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Hepatology 34 (2001) 283-287
7. Bonacini M., and Puoti M. Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. Arch. Intern. Med. 160 (2000) 3365-3373
8. Bukh J., Miller R.H., and Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver Dis. 15 (1995) 41-63
9. Canobio S., Guilbert C., Troesch M., Samson J., Lemay M., Pelletier V.A., Bernard-Bonnin A.C., Kozielski R., Lapointe N., Martin S.R., and Soudeyns H. Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1. J. Clin. Microbiol. 42 (2004) 4365-4369
10. Chen S., and Wang Y.M. Multigene tracking of quasispecies in viral persistence and clearance of hepatitis C virus. World J. Gastroenterol. 11 (2005) 2874-2884
11. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359-362
12. Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P.J., Weiner A.J., Bradley D.W., Kuo G., and Houghton M. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2451-2455
13. Cox A.L., Mosbruger T., Mao Q., Liu Z., Wang X.H., Yang H.C., Sidney J., Sette A., Pardoll D., Thomas D.L., and Ray S.C. Cellular immune selection with hepatitis C virus persistence in humans. J. Exp. Med. 201 (2005) 1741-1752
14. Dauber-Osguthorpe P., Roberts V.A., Osguthorpe D.J., Wolff J., Genest M., and Hagler A.T. Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug-receptor system. Proteins 4 (1988) 31-47
15. Dieterich D.T. Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection. Am. J. Med. 107 (1999) 79S-84S
16. Dodig M., and Tavill A.S. Hepatitis C and human immunodeficiency virus coinfections. J. Clin. Gastroenterol. 33 (2001) 367-374
17. Drummer H., Maerz A., and Poumbourios P. Structural and functional role of a fusion-peptide like sequence in hepatitis C virus glycoprotein E2. Abstracts of the 12th International Meeting on HCV and Related Viruses, Montreal, Canada (2005) 26
18. Dutoit V., Ciuffreda D., Comte D., Gonvers J.J., and Pantaleo G. Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection. Eur. J. Immunol. 35 (2005) 3493-3504
19. Farci P., Shimoda A., Coiana A., Diaz G., Peddis G., Melpolder J.C., Strazzera A., Chien D.Y., Munoz S.J., Balestrieri A., Purcell R.H., and Alter H.J. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288 (2000) 339-344
20. Farci P., Strazzera R., Alter H.J., Farci S., Degioannis D., Coiana A., Peddis G., Usai F., Serra G., Chessa L., Diaz G., Balestrieri A., and Purcell R.H. Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3081-3086
21. Flint M., Maidens C., Loomis-Price L.D., Shotton C., Dubuisson J., Monk P., Higginbottom A., Levy S., and McKeating J.A. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 73 (1999) 6235-6244
22. + T cells. J. Immunol. 163 (1999) 650-658
23. Gaudy C., Moreau A., Veillon P., Temoin S., Lunel F., and Goudeau A. Significance of pretreatment analysis of hepatitis C virus genotype 1b hypervariable region 1 sequences to predict antiviral outcome. J. Clin. Microbiol. 41 (2003) 3615-3622
24. Gonzalez-Peralta R.P., Qian K., She J.Y., Davis G.L., Ohno T., Mizokami M., and Lau J.Y. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J. Med. Virol. 49 (1996) 242-247
25. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2714-2723
26. Heo T.H., Chang J.H., Lee J.W., Foung S.K.H., Dubuisson J., and Kang C.Y. Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of putative multiple receptors by E2 envelope glycoproteins. J. Immunol. 173 (2004) 446-455
27. Honda M., Kaneko S., Sakai A., Unoura M., Murakami S., and Kobayashi K. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 20 (1994) 1144-1151
28. Hsu M., Zhang J., Flint M., Logvinoff C., Cheng-Mayer C., Rice C.M., and McKeating J.A. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped viral particles. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 7271-7276
29. Janin J. Surface and inside volumes in globular proteins. Nature 277 (1979) 491-492
30. Kato N., Ootsuyama Y., Tanaka T., Nakagawa M., Nakazawa T., Muraiso K., Ohkoshi S., Hijikata M., and Shimotohno K. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res. 22 (1992) 107-123
31. Kato N., Sekiya H., Ootsuyama Y., Nakazawa T., Hijikata M., Ohkoshi S., and Shimotohno K. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J. Virol. 67 (1993) 3923-3930
32. Korber B.T.M., Kunstman K.J., Patterson B.K., Furtado M., McEvilly M.M., Levy R., and Wolinsky S.M. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J. Virol. 68 (1994) 7467-7481
33. Kuiken C., Yusim K., Boykin L., and Richardson R. The Los Alamos HCV sequence database. Bioinformatics 21 (2005) 379-384
34. Kumar S., Tamura K., Jakobsen I.B., and Nei M. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17 (2001) 1244-1245
35. Kyte J., and Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157 (1982) 105-132
36. Lauer G.M., Nguyen T.N., Day C.L., Robbins G.K., Flynn T., McGowan K., Rosenberg E.S., Lucas M., Klenerman P., Chung R.T., and Walker B.D. Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses. J. Virol. 76 (2002) 2817-2826
37. Mao Q., Ray S.C., Laeyendecker O., Ticehurst J.R., Strathdee S.A., Vlahov D., and Thomas D.L. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. J. Virol. 75 (2001) 3259-3267
38. Martell M., Esteban J.I., Quer J., Genesca J., Weiner A., Esteban R., Guardia J., and Gomez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66 (1992) 3225-3229
39. Murphy D., Willems B., and Delage G. Use of the 5′ noncoding region for genotyping hepatitis C virus. J. Infect. Dis. 169 (1994) 473-475
40. Nei M., and Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3 (1986) 418-426
41. Owsianka A., Clayton R.F., Loomis-Price L.D., McKeating J.A., and Patel A.H. Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. J. Virol. 82 (2001) 1877-1883
42. Parker J.M., Guo D., and Hodges R.S. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 25 (1986) 5425-5432
43. Pawlotsky J.M. Hepatitis C virus resistance to antiviral therapy. Hepatology 32 (2000) 889-896
44. Penin F., Combet C., Germanidis G., Frainais P.O., Deleage G., and Pawlotsky J.M. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J. Virol. 75 (2001) 5703-5710
45. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., and Abrignani S. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
46. Polyak S.J., Sullivan D.G., Austin M.A., Dai J.Y., Shunhart M.C., Lindsay K.L., Bonkovsky H.L., Di Bisceglie A.M., Lee W.M., Morishima C., and Gretch D.R. Comparison of amplification enzymes for hepatitis C virus quasispecies analysis. Virol J 2 (2005) 41
47. Rey F.A., Heinz F.X., Mandl C., Kunz C., and Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375 (1995) 291-298
48. Rubbia-Brandt L., Leandro G., Spahr L., Giostra E., Quadri R., Male P.J., and Negro F. Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3. Histopathology 39 (2001) 119-124
49. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y., Choo Q.L., Houghton M., and Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 6547-6549
50. Sala M., and Wain-Hobson S. Are RNA viruses adapting or merely changing?. J. Mol. Evol. 51 (2000) 12-20
51. Sali A., and Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234 (1993) 779-815
52. Scarselli E., Ansuini H., Cerino R., Roccasecca R.M., Acali S., Filocamo G., Traboni C., Nicosia A., Cortese R., and Vitelli A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21 (2002) 5017-5025
53. Sherman K.E., Andreatta C., O'Brien J., Gutierrez A., and Harris R. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology 23 (1996) 688-694
54. Shirai M., Arichi T., Chen M., Masaki T., Nishioka M., Ikeda K., Takahashi H., Enomoto N., Saito T., Major M.E., Nakazawa T., Akatsuka T., Feinstone S.M., and Berzofsky J.A. T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region. J. Immunol. 162 (1999) 568-576
55. Simmonds P., Holmes E.C., Cha T.A., Chan S.W., McOmish F., Irvine B., Beall E., Yap P.L., Kolberg J., and Urdea M.S. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74 (1993) 2391-2399
56. Simmonds P., Bukh J., Combet C., Deleage G., Enomoto N., Feistone S., Halfon P., Inchauspe G., Kuiken C., Maertens G., Mizokami M., Murphy D.G., Okamoto H., Pawlotsky J.M., Penin F., Sablon E., Shin-I T., Stuyver L.J., Thiel H.J., Viazov S., Weiner A.J., and Widell A. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42 (2005) 962-973
57. Slater-Handshy T., Droll D.A., Di Bisceglie A.M., and Chambers T.J. HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing. Virology 319 (2004) 36-48
58. Soriano V., Rodriguez-Rosado R., and Garcia-Samaniego J. Management of chronic hepatitis C in HIV-infected patients. AIDS 13 (1999) 539-546
59. Tester I., Smyk-Pearson S., Wang P., Wertheimer A., Yao E., Lewinsohn D.M., Tavis J.E., and Rosen H.R. Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J. Exp. Med. 201 (2005) 1725-1731
60. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., and Higgins D.G. The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25 (1997) 4876-4882
61. Timm J., Lauer G.M., Kavanagh D.G., Sheridan I., Kim A.Y., Lucas M., Pillay T., Ouchi K., Reyor L.L., Zur Wiesch J.S., Gandhi R.T., Chung R.T., Bhardwaj N., Klenerman P., Walker B.D., and Allen T.M. CD8 epitope escape and reversion in acute HCV infection. J. Exp. Med. 200 (2004) 1593-1604
62. Weiner A.J., Brauer M.J., Rosenblatt J., Richman K.H., Tung J., Crawford K., Bonino F., Saracco G., Choo Q.L., and Houghton M. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180 (1991) 842-848
63. Weiner A.J., Geysen H.M., Christopherson C., Hall J.E., Mason T.J., Saracco G., Bonino F., Crawford K., Marion C.D., Crawford K.A., Brunetto M., Barr P.J., Miyamura T., McHutchinson J., and Houghton M. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 3468-3472
64. Wong D.K., Dudley D.D., Afdhal N.H., Dienstag J., Rice C.M., Wang L., Houghton M., Walter B.D., and Koziel M.J. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J. Immunol. 160 (1998) 1479-1488
65. Yagnik A.T., Lahm A., Meola A., Roccasecca R.M., Ercole B.B., Nicosia A., and Tramontano A. A model for the hepatitis C virus envelope glycoprotein E2. Proteins 40 (2000) 355-366